Last reviewed · How we verify
TKCell
At a glance
| Generic name | TKCell |
|---|---|
| Also known as | NKCell, FOLFOX-4 |
| Sponsor | Binex |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Efficacy Study of TKcell in Advanced Colorectal Cancer (PHASE1, PHASE2)
- Efficacy Study of TKcell in Advanced Gastric Cancer (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- TKCell CI brief — competitive landscape report
- TKCell updates RSS · CI watch RSS
- Binex portfolio CI